# Moderna starts human trial of Bundibugyo Ebola vaccine 2026-08-06T19:55:25+00:00 | Health & Science | Indian Opinion Desk Corroboration: 1 independent outlet Moderna has begun a first human trial of an experimental vaccine against Bundibugyo ebolavirus, a strain with no approved vaccine. Health Canada cleared the early-stage study, and the first volunteers have received the mRNA-1469 shot, the company said on August 4. The Canadian trial will involve about 80 healthy adults at three sites and assess safety and immune response. The work is backed by the Coalition for Epidemic Preparedness Innovations, which has pledged up to $50 million. The Bundibugyo outbreak in the Democratic Republic of Congo had recorded 3,748 confirmed cases and 1,657 deaths by August 1, according to US CDC data. Moderna says it plans to provide at least 500,000 doses to lower-income countries if the vaccine is approved. ## Coverage - thehindu.com Tags: Democratic Republic of Congo, Ebola, Moderna, mRNA, vaccines Canonical: https://indianopinion.org/moderna-starts-human-trial-of-bundibugyo-ebola-vaccine/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/moderna-starts-human-trial-of-bundibugyo-ebola-vaccine/#story-in-brief Review state: restored archive article, accurate at time of publication, not offered to search indexes.